Skip to content
PubMed This is a summary of 77 peer-reviewed journal articles Updated
Electrophysiology

Navigating a CPVT Diagnosis

At a Glance

Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a rare genetic heart rhythm disorder triggered by adrenaline surges from intense exercise or emotional stress. A normal resting ECG makes it difficult to diagnose, but it is highly manageable with strict medication and specialist care.

Getting a diagnosis of Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) can feel incredibly overwhelming. Whether you are a young adult who just received this diagnosis or a parent whose child experienced a terrifying fainting episode, it is completely normal to feel scared and confused.

You are not alone. While CPVT is a serious condition, it is manageable with the right medical team and strict adherence to a treatment plan.

What is CPVT?

CPVT is a rare genetic heart rhythm disorder (a channelopathy). In a healthy heart, the electrical system signals the heart muscle to squeeze and pump blood. In CPVT, a genetic mutation causes a “leak” in the way the heart cells handle calcium [1][2].

Under normal, resting conditions, the heart works perfectly fine. However, when the body experiences a surge of adrenaline—such as during intense physical exercise or extreme emotional stress (like anger, fear, or even a sudden startle)—this calcium leak worsens. This triggers a dangerous, rapid heart rhythm called ventricular tachycardia (VT) [1][3]. When the heart beats this fast and irregularly, it cannot pump blood effectively to the brain, leading to fainting (syncope) or, in severe cases, sudden cardiac arrest.

Why is it so hard to diagnose?

One of the most frustrating aspects of CPVT is that a standard resting ECG (electrocardiogram) usually looks completely normal [4][5]. Because the arrhythmias only happen during periods of high adrenaline, many patients are misdiagnosed for years with conditions like epilepsy (seizures) or simple panic attacks [6][7].

How to Use This Guide

This guide is designed to empower you with the knowledge you need to advocate for yourself or your loved one. We recommend reading through the following sections to understand the condition and how to manage it:

You can live a full life with CPVT. The key is strict adherence to medication, avoiding specific triggers, and ensuring your care team specializes in pediatric or adult electrophysiology.

Common questions in this guide

What is CPVT?
Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) is a rare genetic heart disorder caused by a calcium leak in heart cells. It causes dangerously fast and irregular heartbeats when a person experiences a surge of adrenaline, such as during intense exercise or strong emotional stress.
Why is CPVT so hard to diagnose?
CPVT is difficult to diagnose because standard resting electrocardiograms (ECGs) usually look completely normal. The dangerous heart rhythms only appear when the heart rate is elevated by adrenaline, leading to frequent misdiagnoses like epilepsy or panic attacks.
What triggers a CPVT episode?
CPVT episodes are triggered by sudden surges of adrenaline. Common triggers include intense physical activity, sudden startling noises, or extreme emotional stress like fear and anger.
What are the symptoms of CPVT?
The most common symptoms are unexplained fainting or severe dizziness during physical exertion or high emotional stress. In severe cases, the irregular heart rhythm can lead to sudden cardiac arrest.
Can CPVT be treated?
While CPVT is a serious condition, it can be managed effectively to allow for a full life. Treatment typically involves strict adherence to daily medications, avoiding specific adrenaline triggers, and working closely with a specialized electrophysiology team.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.How many patients with Catecholaminergic Polymorphic Ventricular Tachycardia (CPVT) does your clinic currently treat?
  2. 2.Which specific tests will we use to confirm the diagnosis and establish my baseline heart rate limits?
  3. 3.What is our preferred way to reach your electrophysiology team quickly if we have a non-emergency question about a symptom or medication side effect?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (7)
  1. 1

    The Purkinje-myocardial junction is the anatomic origin of ventricular arrhythmia in CPVT.

    Blackwell DJ, Faggioni M, Wleklinski MJ, et al.

    JCI insight 2022; (7(3)).

    PMID: 34990403
  2. 2

    Sudden death after inappropriate shocks of implantable cardioverter defibrillator in a catecholaminergic polymorphic ventricular tachycardia case with a novel RyR2 mutation.

    Itoh H, Murayama T, Kurebayashi N, et al.

    Journal of electrocardiology 2021; (69()):111-118 doi:10.1016/j.jelectrocard.2021.09.015.

    PMID: 34656916
  3. 3

    Efficacy of ivabradine to control ventricular arrhythmias in catecholaminergic polymorphic ventricular tachycardia.

    Vaksmann G, Klug D

    Pacing and clinical electrophysiology : PACE 2018; (41(10)):1378-1380 doi:10.1111/pace.13446.

    PMID: 29989676
  4. 4

    Identification of a novel exon3 deletion of RYR2 in a family with catecholaminergic polymorphic ventricular tachycardia.

    Dharmawan T, Nakajima T, Ohno S, et al.

    Annals of noninvasive electrocardiology : the official journal of the International Society for Holter and Noninvasive Electrocardiology, Inc 2019; (24(3)):e12623 doi:10.1111/anec.12623.

    PMID: 30615235
  5. 5

    Insights Into the Pathogenesis of Catecholaminergic Polymorphic Ventricular Tachycardia From Engineered Human Heart Tissue.

    Park SJ, Zhang D, Qi Y, et al.

    Circulation 2019; (140(5)):390-404 doi:10.1161/CIRCULATIONAHA.119.039711.

    PMID: 31311300
  6. 6

    Catecholaminergic Polymorphic Ventricular Tachycardia.

    Wall JJ, Iyer RV

    Pediatric emergency care 2017; (33(6)):427-431 doi:10.1097/PEC.0000000000001156.

    PMID: 28570361
  7. 7

    Bilateral cardiac sympathetic denervation in catecholaminergic polymorphic ventricular tachycardia.

    Stec S, Zamorski P, Wołek W, et al.

    Kardiologia polska 2019; (77(6)):653-654 doi:10.33963/KP.14834.

    PMID: 31099757

This guide provides educational information about CPVT. It is not a substitute for professional medical advice, diagnosis, or treatment from a qualified electrophysiologist or cardiologist.

Get notified when new evidence is published on Catecholaminergic polymorphic ventricular tachycardia.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.